Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)
about
Hydroxychloroquine-related retinal toxicityRole of the macular optical coherence tomography scan in neuro-ophthalmologyThe impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.Validation of the colour difference plot scoring system analysis of the 103 hexagon multifocal electroretinogram in the evaluation of hydroxychloroquine retinal toxicity.Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathyRetinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic studySpectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients.Scotoma analysis of 10-2 visual field testing with a red target in screening for hydroxychloroquine retinopathy.Retinal nerve fiber layer and macular thinning in systemic lupus erythematosus: an optical coherence tomography study comparing SLE and neuropsychiatric SLE.Hydroxychloroquine retinopathy: A review of imagingA case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment: a review of the literature on the use of hydroxychloroquine in renal impairment.Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy.Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy.Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography.Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment.Screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testingThe effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case reportHydroxychloroquine retinopathy: an emerging problem.Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis.Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.Expanded spectral domain-OCT findings in the early detection of hydroxychloroquine retinopathy and changes following drug cessation.Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
P2860
Q26782822-2F2297CD-BEBF-43B7-89BA-54D3DB35943BQ33352546-6978485F-1EFA-42DD-8D80-7BC886089C84Q33976159-7CE153AC-4B35-4C86-A0E8-75200243287FQ34005507-EA5C70DF-BFDB-4DA1-9260-5A13D50D004DQ34349813-78EB433A-D9BF-436F-AF07-4ADA77B417C0Q34520106-CB310537-AE85-4E66-AA1B-CC9254010A53Q35001994-AF27331E-FE24-444B-918A-61CC49455AA2Q35679381-BCC8C1FE-3D10-4380-8D00-18F44973B4BAQ35839727-30E9777E-98E3-4E3F-96B5-BF0E48AE8647Q35957874-1F2D46B8-6402-4D79-BAF7-10EA0911F373Q35994318-F1E69C7E-B3B2-4DEB-8BF4-01CF61BE6192Q36052684-D0C34F1A-56C9-4EC5-B14D-9742BE2900CFQ36298100-2E6B4145-B3E6-49AD-BA06-3475B2F43CECQ36470464-5A607A2C-23D0-4167-88FF-BE1B4EE2D3BBQ36627171-90E55698-F922-4FC3-AB91-EE42B652361CQ37168797-E3FC34AC-7662-4E37-AB7A-1979B2C1B369Q37253124-28C2B55E-041B-418F-9F46-4E982CBB6D4CQ37952267-94F02A81-5E15-41F4-9BC5-8DFCE22039F1Q39396583-4A139145-D6AB-41FD-B5AE-E2AA6897040FQ41002662-9D557CE0-E3DE-41C9-B90F-18C63E1D8990Q41913394-83DEAC1B-BA27-41E7-9F79-E36FC91AFEF5Q41920639-04E9AC44-82B8-46FA-9EF9-852F0F6232E1Q48157720-C78BAEEC-B380-42DB-8532-AC96F458BEF3Q50228699-ABB2489F-916C-4DF3-B6C6-456CF0A6B9A4Q52676550-6768D9A3-B41A-4850-8CAC-6226D1DB1866Q55222190-50EAB4A8-2916-4A8C-A405-DF1ED4F80531
P2860
Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign)
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@ast
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@en
Spectral domain optical cohere ...... hydroxychloroquine retinopathy
@nl
type
label
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@ast
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@en
Spectral domain optical cohere ...... hydroxychloroquine retinopathy
@nl
prefLabel
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@ast
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@en
Spectral domain optical cohere ...... hydroxychloroquine retinopathy
@nl
P2093
P2860
P356
P1476
Spectral domain optical cohere ...... thy (the "flying saucer" sign)
@en
P2093
David M Brown
James C Major
Matthew S Benz
Richard H Fish
Rosa Y Kim
Tien P Wong
P2860
P304
P356
10.2147/OPTH.S14257
P407
P577
2010-10-21T00:00:00Z